| Literature DB >> 25848586 |
Xiaoqian Jiang1, Yuan Wu2, Keith Marsolo3, Lucila Ohno-Machado1.
Abstract
OBJECTIVE: We describe functional specifications and practicalities in the software development process for a web service that allows the construction of the multivariate logistic regression model, Grid Logistic Regression (GLORE), by aggregating partial estimates from distributed sites, with no exchange of patient-level data.Entities:
Year: 2014 PMID: 25848586 PMCID: PMC4371401 DOI: 10.13063/2327-9214.1053
Source DB: PubMed Journal: EGEMS (Wash DC) ISSN: 2327-9214
Figure 1.Privacy-Preserving Global Model Construction through Secure Multiparty Computing (SMC)
Figure 2.An Overview of the WebGLORE System
Note: The system leverages a secure communication protocol to interact with participating institutions to construct the global logistic regression model from distributed data sets. No records are exchanged or transmitted into a central node. The GLORE code communicated with participating institutes to get estimates from local data and aggregates them to build and evaluate a global model. [Source: Reproduced with permission from Kim et al., JAMIA34]
Figure 4.High-Level Pipeline of the Collaborative Framework of WebGLORE
Figure 5.Detailed Workflow of WebGLORE That Illustrates Its Major Components
GLORE Estimated Parameters and Statistics Using the Wisconsin Breast Cancer Data Set
| Intercept | −10.1039 | 1.1749 | −8.5999 | <0.0001 |
| Clump Thickness | 0.535 | 0.142 | 3.7672 | 0.0002 |
| Uniformity of Cell Size | −0.0063 | 0.2091 | −0.03 | 0.976 |
| Uniformity of Cell Shape | 0.3227 | 0.2306 | 1.3994 | 0.1617 |
| Marginal Adhesion | 0.3306 | 0.1235 | 2.6783 | 0.0074 |
| Single Epithelial Cell Size | 0.0966 | 0.1566 | 0.6171 | 0.5372 |
| Bare Nuclei | 0.383 | 0.0938 | 4.0815 | <0.0001 |
| Bland Chromatin | 0.4472 | 0.1714 | 2.6093 | 0.0091 |
| Normal Nucleoli | 0.213 | 0.1129 | 1.8873 | 0.0591 |
| Mitoses | 0.5348 | 0.3288 | 1.6267 | 0.1038 |
GLORE Estimated Parameters and Statistics Using the ImproveCareNow Data Set
| Intercept | −1.369 | 3.3874 | −0.4124 | 0.6801 |
| Patient on biologics | 0.7773 | 1.0627 | 0.7314 | 0.4645 |
| Days since diagnosis | 0.0002 | 0.0006 | 0.3075 | 0.7585 |
| Gender | −0.4021 | 0.9262 | −0.4342 | 0.6642 |
| Race | 0.2650 | 0.3983 | 0.665 | 0.5058 |
| Age in years at start of treatment | −0.0234 | 0.1489 | −0.1572 | 0.8751 |
| Extent of disease | 0.0893 | 0.1409 | 0.6336 | 0.5263 |
| Patient on thiopurine | 0.7574 | 0.6623 | 1.1437 | 0.2527 |
| Patient on methotrexate | 0.0000 | 3162.2777 | 0.0000 | 1.0000 |
| Patient on salicylate | 1.9536 | 1.1546 | 1.6919 | 0.0907 |
| Patient on steroids | 0.8684 | 0.6580 | 1.3197 | 0.1869 |